标题
Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 14, Pages 3393
出版商
MDPI AG
发表日期
2019-07-10
DOI
10.3390/ijms20143393
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Verapamil Attenuated Prediabetic Neuropathy in High-Fat Diet-Fed Mice through Inhibiting TXNIP-Mediated Apoptosis and Inflammation
- (2019) Lingling Xu et al. Oxidative Medicine and Cellular Longevity
- The Role of Iron and Nerve Inflammation in Diabetes Mellitus Type 2-Induced Peripheral Neuropathy
- (2019) Sabine Paeschke et al. NEUROSCIENCE
- ROCK2 Regulates Monocyte Migration and Cell to Cell Adhesion in Vascular Endothelial Cells
- (2019) Yusuke Takeda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
- (2019) Hiddo J. L. Heerspink et al. DIABETOLOGIA
- A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes
- (2019) Monika A. Niewczas et al. NATURE MEDICINE
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial
- (2019) Carol Pollock et al. Lancet Diabetes & Endocrinology
- The Promise of Systems Biology for Diabetic Kidney Disease
- (2018) Frank C. Brosius et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
- (2018) Keizo Kanasaki CLINICAL SCIENCE
- M1/M2 macrophages in diabetic nephropathy: Nrf2/HO-1 as therapeutic targets
- (2018) R. Clive Landis et al. CURRENT PHARMACEUTICAL DESIGN
- The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure
- (2018) Merlin C. Thomas et al. DIABETOLOGIA
- AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions
- (2018) Davoud Sanajou et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes
- (2018) W. Timothy Garvey et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial
- (2018) Katherine R Tuttle et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Metformin Regulating miR-34a Pathway to Inhibit Egr1 in Rat Mesangial Cells Cultured with High Glucose
- (2018) Can Wu et al. International Journal of Endocrinology
- Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease
- (2018) Bancha Satirapoj et al. BMC Nephrology
- Nrf2 Activation Provides Atheroprotection in Diabetic Mice Through Concerted Upregulation of Antioxidant, Anti-inflammatory, and Autophagy Mechanisms
- (2018) Iolanda Lazaro et al. Frontiers in Pharmacology
- Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
- (2018) Julio Rosenstock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Characterization and comparison of SGLT2 inhibitors: Part 3. Effects on diabetic complications in type 2 diabetic mice
- (2017) Atsuo Tahara et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy
- (2017) Daiji Kawanami et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk
- (2017) Allison B. Goldfine et al. JOURNAL OF CLINICAL INVESTIGATION
- Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice
- (2017) Hongyu Zhang et al. KIDNEY INTERNATIONAL
- SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice
- (2017) Liang Xu et al. EBioMedicine
- Association of Urinary Biomarkers of Inflammation, Injury, and Fibrosis with Renal Function Decline: The ACCORD Trial
- (2016) G. N. Nadkarni et al. Clinical Journal of the American Society of Nephrology
- Inflammation as a Therapeutic Target for Diabetic Neuropathies
- (2016) Rodica Pop-Busui et al. Current Diabetes Reports
- Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men
- (2016) M. H. A. Muskiet et al. DIABETES OBESITY & METABOLISM
- Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease
- (2016) Michelle J. Pena et al. DIABETOLOGIA
- Macrophages in diabetic nephropathy in patients with type 2 diabetes
- (2016) Celine Q.F. Klessens et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria
- (2016) Jan Menne et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
- (2016) Eri H. Kobayashi et al. Nature Communications
- Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology
- (2016) Olga Simó-Servat et al. Journal of Diabetes Research
- Vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1, is associated with diabetic kidney disease in Asians with type 2 diabetes
- (2015) Jian-Jun Liu et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Mycophenolate Mofetil Ameliorates Diabetic Nephropathy in db/db Mice
- (2015) Jung-Woo Seo et al. Biomed Research International
- Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets
- (2015) Stephanie Toth-Manikowski et al. Journal of Diabetes Research
- Metformin Inhibits Monocyte-to-Macrophage Differentiation via AMPK-Mediated Inhibition of STAT3 Activation: Potential Role in Atherosclerosis
- (2015) Sathish Babu Vasamsetti et al. DIABETES
- Effects of the Once-Weekly Glucagon-Like Peptide-1 Receptor Agonist Dulaglutide on Ambulatory Blood Pressure and Heart Rate in Patients With Type 2 Diabetes Mellitus
- (2014) Keith C. Ferdinand et al. HYPERTENSION
- Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors
- (2013) M. Barbieri et al. ATHEROSCLEROSIS
- Fasudil inhibits ER stress-induced VCAM-1 expression by modulating unfolded protein response in endothelial cells
- (2013) Daiji Kawanami et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: A prospective study
- (2013) Jacobien C. Verhave et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Rho-kinase inhibition prevents the progression of diabetic nephropathy by downregulating hypoxia-inducible factor 1α
- (2013) Keiichiro Matoba et al. KIDNEY INTERNATIONAL
- The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential
- (2013) Hiroki Fujita et al. KIDNEY INTERNATIONAL
- Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-κB pathways in diabetic neuropathy
- (2013) Veera Ganesh Yerra et al. Redox Biology
- Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition
- (2012) Swenja Kröller-Schön et al. CARDIOVASCULAR RESEARCH
- Circulating TNF Receptors 1 and 2 Predict ESRD in Type 2 Diabetes
- (2012) M. A. Niewczas et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Inflammation in Diabetic Nephropathy
- (2012) Andy K. H. Lim et al. MEDIATORS OF INFLAMMATION
- Knockout of Toll-Like Receptor-2 Attenuates Both the Proinflammatory State of Diabetes and Incipient Diabetic Nephropathy
- (2011) Sridevi Devaraj et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Thrombin induces MCP-1 expression through Rho-kinase and subsequent p38MAPK/NF-κB signaling pathway activation in vascular endothelial cells
- (2011) Daiji Kawanami et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
- (2011) Hongting Zheng et al. DIABETES
- Potential Role of Regulatory T Cells in Reversing Obesity-Linked Insulin Resistance and Diabetic Nephropathy
- (2011) Kathrin Eller et al. DIABETES
- Transcriptome Analysis of Human Diabetic Kidney Disease
- (2011) K. I. Woroniecka et al. DIABETES
- Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
- (2011) R. Kodera et al. DIABETOLOGIA
- Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
- (2011) Pablo E. Pergola et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rho Kinase-2 Activation in Human Endothelial Cells Drives Lysophosphatidic Acid-mediated Expression of Cell Adhesion Molecules via NF-κB p65
- (2010) Hideaki Shimada et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Critical role for osteopontin in diabetic nephropathy
- (2010) Susanne B. Nicholas et al. KIDNEY INTERNATIONAL
- Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice
- (2009) A. K. H. Lim et al. DIABETOLOGIA
- Microvascular Reactivity and Inflammatory Cytokines in Painful and Painless Peripheral Diabetic Neuropathy
- (2009) John Doupis et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More